Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Patient-Reported Outcome Data Helps Dermira’s Hyperhidrosis Drug Qbrexza Win US FDA Nod

Jul 09 2018

• By Sue Sutter

Sweaty spot on the shirt because of the heat, worries and diffidence

Related Content

FDA's Final PRO Guidance Grounds Policy With More Details

Dec 08 2009

Allergan's Botox Will Target 1.3 Mil. Severe Primary Axillary Hyperhidrosis Patients

Jul 20 2004

Getting With The PRO-gram: Making Patient-Reported Outcomes Work

Nov 24 2014

No Sweat – Hyperhidrosis Patients Seek Broader Approvals; Botox Access An Issue

Nov 16 2017

Dermira Wins First FDA Approval, Preps Qbrexza For October Launch In Hyperhidrosis

Jul 02 2018

Incyte’s Jakafi Gets Additional Claim Based On Patient-Reported Outcomes

Nov 21 2011

Related Companies

Dermira Inc.

Allergan plc

Additional Topics

United States Approvals Regulation Clinical Trials Dermatology BioPharmaceutical

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window